Clinical Benefits of Drug-Eluting Stents
Authors:
- Michelle M. FennessyMFMichelle M. Fennessy
- William B. BordenWBWilliam B. Borden
- 1 November 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Nursing
- Vol. 21 (6) , 442-450
Abstract
Drug-eluting stents have revolutionized interventional cardiology by incorporating drug and device therapy to reduce rates of restenosis. Early trials have addressed the safety and efficacy of drug-eluting stents. Recent studies have evaluated the use of drug-eluting stents in high-risk populations that were not initially randomized in the early trials. These stents have shown promising outcomes in diabetes, in-stent restenosis, and multivessel disease. The clinical benefits of these stents have been systematically quantified across multiple trials; however, there is a growing debate regarding restenosis and late-stent thrombosis after implantation. Given the expanding indications for drug-eluting stents, the American Heart Association identified it as one of the Top 10 Research Advances for 2005. The purpose of this article is to summarize the current debate surrounding late-stent thrombosis, examine the evidence from leading stent trials, and outline the clinical benefits of drug-eluting stents.Keywords
This publication has 30 references indexed in Scilit:
- Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyThe Lancet, 2004
- Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary StentCirculation, 2004
- Coronary Restenosis After Sirolimus-Eluting Stent ImplantationCirculation, 2003
- Drug-Eluting Stents To Prevent Reblockage of Coronary ArteriesJournal of Cardiovascular Nursing, 2003
- Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) TrialCirculation, 2002
- Sirolimus-Eluting Coronary StentsNew England Journal of Medicine, 2002
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Clinical and quantitative coronary angiographic predictors of coronary restenosisJACC, 2001
- Restenosis Rates in Diabetic PatientsCirculation, 1997
- Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patientsAmerican Heart Journal, 1990